Nessuna connessione a internet — viene mostrata la versione salvata della pagina.

Bristol-Myers Squ…

USUSD
← Allo Screener

Bristol-Myers Squibb Company (LSE:0R1F) — Drug Manufacturers - General. Numero di borse in cui sono quotate le azioni della società: 6. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.

Informazioni sull'Azienda

Sito Web
bms.com
Relazioni con gli Investitori
bms.com/investors.html
Settore
Healthcare · Drug Manufacturers - General
Sede Centrale
PRINCETON, United States
Amministratore Delegato
Christopher S. Boerner
Dipendenti
32 500
Fondata
1989
Azioni in Circolazione
2.04 Mld al 2026-07-22
Flottante
2.04 Mld
Capitalizzazione di Mercato
128.41 Mld USD
Insider
0.1%
Investitori Istituzionali
84.87%
Settore (SIC)
Pharmaceutical Preparations
Forma Giuridica
XTIQ
ISIN
US1101221083
LEI
HLYYNH7UQUORYSJQCN42
Payout Ratio
54.9%
FCF
11.4 Mld USD
45%
Debito
43.9 Mld USD
3.1 anni di FCF
Serie di Dividendi
54 a.
Utili, FCF e dividendi pagati — per i 12 mesi fino a 30.06.2026 (l'ultimo rapporto dell'azienda).
Descrizione

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Opdualag to treat unresectable or metastatic melanoma; and Camzyos for the treatment of symptomatic obstructive HCM. The company also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu to treat moderate-to-severe plaque psoriasis; Krazati for the treatment of KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for the reduction of risk of stroke/systemic embolism and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug for multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane to treat breast cancer. Further, the company provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC, as well as NSCLC and pancreatic cancer. It sells its products to wholesalers, distributors, specialty pharmacies, retailers, hospitals, clinics, and government agencies. The company has a strategic collaboration with Arcus Biosciences, Inc. to develop a treatment regimen that delivers tumor control in kidney cancer. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.

Borse e Ticker

BorsaTickerValutaPrezzoTipo
US USA StocksBMY principaleUSD59.58 -0.20%azioni ordinarie
LSE London Stock Exchange0R1F IOBGBP—azioni ordinarie
MI Borsa Italiana (Milan)1BMY secondariaEUR53.13 +0.28%azioni ordinarie
MX Mexican Stock ExchangeBMY secondariaMXN1 088.5 +1.73%azioni ordinarie
VI Vienna Stock ExchangeBMYS secondariaEUR52.98 +0.34%azioni ordinarie
XETRA XetraBRM secondariaEUR53.04 +0.89%azioni ordinarie

Prezzo su 3 Mesi

giorno di rialzo giorno di ribasso data di stacco del dividendo data di pagamentoPassa il mouse / tocca un giorno — prezzi di apertura, chiusura, massimo e minimo

Dividendi

All'anno, US:BMY: 2.52 USD (4 pag.)

Bristol-Myers Squibb Company (BMY) paga dividendi trimestralmente. All'anno (12 mesi fino all'ultimo pagamento annunciato): 2.52 USD per azione (pagamenti: 4). Questo rappresenta circa il 4.23% del prezzo attuale delle azioni. In base alla storia dei pagamenti, la prossima data ex-dividendo è prevista intorno al 01.01.2027. Storia dei dividendi ininterrotta: 54 anni.

Data ExPagamentoImporto%TipoTicker
2026-10-022026-11-020.6300 USD1.1/4.2 %trimestraleUS:BMY
2026-07-022026-08-030.6300 USD1.1/4.2 %trimestraleUS:BMY
2026-04-022026-05-010.6300 USD1.1/4.2 %trimestraleUS:BMY
2026-01-022026-02-020.6300 USD1.1/4.2 %trimestraleUS:BMY
2025-10-032025-11-030.6200 USD1.0/4.2 %trimestraleUS:BMY
2025-07-032025-08-010.6200 USD1.0/4.1 %trimestraleUS:BMY
2025-04-042025-05-010.6200 USD1.0/4.1 %trimestraleUS:BMY
2025-01-032025-02-030.6200 USD1.0/4.1 %trimestraleUS:BMY
2024-10-042024-11-010.6000 USD1.0/4.0 %trimestraleUS:BMY
2024-07-052024-08-010.6000 USD1.0/≈4.0 %trimestraleUS:BMY
2024-04-042024-05-010.6000 USD1.0/2.0 %trimestraleUS:BMY
2024-01-042024-02-010.6000 USD1.0/1.0 %trimestraleUS:BMY

Notizie di Questa Settimana

Comunicati stampa dal sito web per investitori della società, aggiornati quotidianamente. I link conducono al sito web dell'azienda. I titoli sono nella lingua originale, come sul sito web dell'azienda.

pubblicità

Principali Azionisti

DetentoreQuotaAzioniData del Rapporto
Blackrock Inc.8.83%180.38 Mln2026-06-30
Vanguard Capital Managem…6.53%133.34 Mln2026-06-30
State Street Corporation5.01%102.41 Mln2026-06-30
JPMORGAN CHASE & CO3.51%71.71 Mln2026-06-30
Charles Schwab Investmen…3.31%67.6 Mln2026-06-30
VANGUARD INDEX FUNDS-Van…3.17%64.83 Mln2026-06-30
Geode Capital Management…2.76%56.44 Mln2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%52.92 Mln2026-06-30
SCHWAB STRATEGIC TRUST-S…2.38%48.64 Mln2026-05-31
Vanguard Portfolio Manag…2.29%46.87 Mln2026-06-30
NORGES BANK1.8%36.87 Mln2026-06-30
Bank of America Corporat…1.67%34.05 Mln2026-06-30
Price (T.Rowe) Associate…1.55%31.71 Mln2026-06-30
iShares Trust-iShares Co…1.35%27.55 Mln2026-08-31
Fidelity Concord Street…1.29%26.41 Mln2026-07-31
SPDR S&P 500 ETF TRUST-S…1.22%24.96 Mln2026-08-31
VANGUARD INDEX FUNDS-Van…0.95%19.44 Mln2026-06-30
SELECT SECTOR SPDR TRT-S…0.72%14.68 Mln2026-08-31
VANGUARD CHESTER FUNDS-V…0.7%14.29 Mln2026-06-30
VANGUARD INSTITUTIONAL I…0.54%11.09 Mln2026-06-30
LEUNG SANDRA (General Co…≈0.02%465 3742025-03-10
ELKINS DAVID VINCENT (Ch…≈0.01%159 5422026-04-01
BOERNER CHRISTOPHER S (C…≈0.01%146 8902026-03-10
HIRAWAT SAMIT (Officer)≈0%83 5132025-04-25
HALLER JULIA A (Director…≈0%34 0792026-06-15
MEYERS GREGORY SCOTT (Ch…≈0%30 3612026-03-10
LENKOWSKY ADAM (Officer)≈0%28 6772026-05-01
SHANAHAN KARIN (Officer)≈0%27 3452026-04-01
PLENGE ROBERT M (Officer…≈0%24 7542026-03-10
MASSACESI CRISTIAN (Offi…≈0%18 7482026-09-09